(Q37900305)

25 August 2017

1 reference

title

Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines (English)

1 reference

25 August 2017

author

Maryna C Eichelberger

series ordinal

1

object named as

Maryna C Eichelberger

1 reference

25 August 2017

Martin D Green

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

Expert Opinion on Drug Metabolism & Toxicology

25 August 2017

published in

1 reference

25 August 2017

volume

7

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

1117-1127

1 reference

Influenza vaccines: from surveillance through production to protection.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Animal models for the preclinical evaluation of candidate influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza vaccines for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Live attenuated vaccines for pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Designing vaccines for pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Research and development of universal influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Pandemic preparedness: toward a universal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza virus CTL epitopes, remarkably conserved and remarkably variable.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Animal models for evaluation of influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Sialic acid species as a determinant of the host range of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Host range restriction and pathogenicity in the context of influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

A naturally occurring variant of porcine Mx1 associated with increased susceptibility to influenza virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Host response to influenza virus: protection versus immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

The cotton rat as a model to study influenza pathogenesis and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza virus infection of the guinea pig: Immune response and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

The guinea pig as a transmission model for human influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Blocking interhost transmission of influenza virus by vaccination in the guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

A Virus Obtained from Influenza Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Animal models in influenza vaccine testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Development and characterization of cold-adapted viruses for use as live virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

THE SUSCEPTIBILITY OF SWINE TO THE VIRUS OF HUMAN INFLUENZA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Avian H5N1 influenza in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Experimental pandemic (H1N1) 2009 virus infection of cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Transcutaneous immunization of domestic animals: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Pathogenesis of influenza A (H5N1) virus infection in a primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Seasonal influenza vaccine provides priming for A/H1N1 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

B-cell activation by superstimulatory influenza virus hemagglutinin: a pathogenesis for autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2011.602065

10.1517/17425255.2011.602065

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference